A CK1a Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.

A CK1a Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma. Clin Cancer Res. 2019 02 15; 25(4):1379-1388.

View in: PubMed

subject areas

Anilides
Animals
Benzoates
Brain
Casein Kinase Ialpha
Disease Models, Animal
Drug Resistance, Neoplasm
Heterografts
Humans
Medulloblastoma
Mice
Neoplasm Metastasis
N-Myc Proto-Oncogene Protein
Pyridines
Signal Transduction
Smoothened Receptor
Tumor Suppressor Protein p53
Zinc Finger Protein GLI1

authors with profiles

Jezabel Rodriguez-Blanco